COMMUNIQUÉS West-GlobeNewswire

First Insight Corporation Welcomes Whitney Smith, LDO as Senior Sales Representative
10/09/2026
Sixteen-year eye care veteran will cover the Southeast and bring MaximEyesAI to more practices PORTLAND, Ore., Sept. 10, 2026 (GLOBE NEWSWIRE) -- First Insight Corporation, developer of the MaximEyes eye care platform, [...]
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
10/09/2026
Regulatory and quality expertise strengthens Board as Candel advances toward planned Biologics License Application (BLA) submission and potential commercial readiness NEEDHAM, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- [...]
NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
10/09/2026
SANTA ANA, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
10/09/2026
Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt ORANGE, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Ninety percent of seniors report at least one factor affecting [...]
Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica
10/09/2026
Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative medical imaging [...]
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
DOYLESTOWN, Pa., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of [...]
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
10/09/2026
Accomplished biopharmaceutical finance executive brings extensive experience driving capital markets activities, strategic transactions, and growth across public companies JERSEY CITY, N.J., Sept. 10, 2026 (GLOBE [...]
Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
10/09/2026
PARAMUS, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, today [...]
ORYZON to Participate in Upcoming Events in September and October
10/09/2026
MADRID and CAMBRIDGE, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its [...]
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
10/09/2026
Amended terms of agreement include a transition to an integrated asset and technology partnership. SAN DIEGO and SUZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform- [...]
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
10/09/2026
SHENZHEN, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- On September 9, BGI Group held its 2026 Global New Product Launch Event at BGI Center in Shenzhen, marking the organization’s 27th anniversary. Under the theme “ [...]
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NORCROSS, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that company management will present and [...]
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune [...]
Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
10/09/2026
Healthy volunteer study will evaluate ingestible delivery capsule for oral, needle-free administration of adalimumab with topline data expected by early 2027 SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Biora [...]
Ethris and EIB sign €30M financing under HERA Invest to advance further clinical development of broad-spectrum nasal antiviral
10/09/2026
Funding will support Ethris in the development of its portfolio of respiratory mRNA products for chronic respiratory diseases and pandemic preparedness. EIB’s financing is backed up by DG HERA, as part of the European [...]
Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes
10/09/2026
TEL AVIV, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“ Teva ”) announced today that it successfully priced its offering of approximately $4.9 billion ( [...]
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
10/09/2026
ALACHUA, Fla. and TAMPA, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of [...]
Kestra Names Daniel Finney Vice President of Research & Development
10/09/2026
KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named [...]
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
10/09/2026
Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen’s addressable market within its focus markets Axogen’s commercial infrastructure, surgeon relationships [...]

Pages